Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **CD3 antigen** is a multimeric protein complex and a definitive surface marker of **T cells**, where it functions as a key component of the T cell receptor (TCR) complex[1][3][7]. It consists of four main subunits: CD3γ, CD3δ, CD3ε, and CD3ζ, assembled as three dimers (γε, δε, ζζ), each with transmembrane and cytoplasmic domains containing immunoreceptor tyrosine-based activation motifs (ITAMs)[1][3][5][7]. CD3 associates non-covalently with the TCR and mediates signal transduction upon antigen recognition, leading to T cell activation, proliferation, differentiation, and effector function[1][2][3][7]. Because of its central role in T cell biology, **CD3 is a major therapeutic target** in immunology—for example, by using anti-CD3 antibodies to either activate or suppress the immune response in settings including transplantation, autoimmunity, and cancer immunotherapy[2][6][7]. CD3 is broadly expressed on all mature T cells, making it a standard marker for T cell identification and quantification in research and clinical diagnostics[5][7]. Notable clinical risks of therapeutics targeting CD3 include cytokine release syndrome and increased susceptibility to infection due to immunosuppression[2][7].
TCR signaling modulation, Immune modulation via T cell activation or depletion, Induction of T cell apoptosis (in some therapeutic contexts), Immune synapse formation
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD3 antigen (T cell co-receptor) (CD3).